# 60 Degrees Pharmaceuticals, Inc.: Form 8-K, filed Feb 20, 2024

- Company: [60 Degrees Pharmaceuticals, Inc.](/companies/sxtp.md) (CIK 1946563)
- Form: 8-K
- Filed: 2024-02-20
- Accepted by EDGAR: Feb 20, 2024, 16:00 ET
- Period: 2024-02-13
- Accession: 0001213900-24-015295
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1946563/000121390024015295/ea0200322-8k_60degrees.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1946563/000121390024015295/

## Items reported

- Item 1.01: Entry into a material agreement
- Item 8.01: Other events
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1946563/000121390024015295/ea0200322-8k_60degrees.htm

Filed Feb 20, 2024.
Source: SEC EDGAR, the filing index for accession 0001213900-24-015295. Last ingested by Listed: Nov 13, 2026, 16:16 ET. No prices; not investment advice.
